ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
3.100
+0.680 (28.10%)
At close: Jul 2, 2025, 4:00 PM
3.050
-0.050 (-1.61%)
After-hours: Jul 2, 2025, 7:59 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $50.38 million as of July 2, 2025. Its market cap has increased by 459.76% in one year.
Market Cap
50.38M
Enterprise Value
48.98M
1-Year Change
459.76%
Ranking
Category
Stock Price
$3.10
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $50.38M, a decrease of -36.63%. That is a compound annual growth rate of -11.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 40.60M | 427.27% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |